Skip to main content
Top
Published in: Calcified Tissue International 5/2004

01-05-2004

Plasma Leptin Concentration and Change in Bone Density Among Elderly Men and Women: The Hertfordshire Cohort Study

Authors: E. M. Dennison, H. E. Syddall, C. H. Fall, M. K. Javaid, N. K. Arden, D. I. W. Phillips, C. Cooper

Published in: Calcified Tissue International | Issue 5/2004

Login to get access

Abstract

Several studies have shown an association between circulating leptin concentration and bone mineral density, but most studies are cross-sectional in design and report findings in women only. We performed a population-based longitudinal study relating baseline plasma leptin concentration to bone mass at the lumbar spine and femoral neck and to change in bone density at these sites over four years in a cohort of 302 men and women aged 60–75 years born and still resident in Hertfordshire, UK. Baseline plasma leptin concentration was strongly positively correlated with body mass index (men: r = 0.71, P < 0.000l; women: r = 0.79, P < 0.0001) and with bone mineral content, bone mineral density, and volumetric bone mineral density at all sites (r = 0.24–0.36, P < 0.001) in both sexes; associations with change in bone density were markedly weaker and inconsistent. Adjustment for adult lifestyle determinants of osteoporosis made little difference to our results, but the associations of leptin with bone mass were no longer significant after adjustment for body mass index. These results suggest that the relationship between plasma leptin and bone mass is similar in men and women and that it is mediated through the strong association of both variables with adiposity, rather than through a direct association of leptin on bone cell function.
Literature
1.
go back to reference Goulding, A, Taylor, RW 1998Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women.Calcif Tissue Int63456458PubMed Goulding, A, Taylor, RW 1998Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women.Calcif Tissue Int63456458PubMed
2.
go back to reference Martini, G, Valenti, R, Giovani, S, Franci, B, Campagna, S, Nuti, R 2001Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women.Bone28113117PubMed Martini, G, Valenti, R, Giovani, S, Franci, B, Campagna, S, Nuti, R 2001Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women.Bone28113117PubMed
3.
go back to reference Iwamoto, I, Douchi, T, Kosha, S, Murakami, M, Fujino, T, Nagata, Y 2000Relationships between serum leptin level and regional bone mineral density, bone metabolic markers in healthy women.Acta Obstet Gynecol Scand7910601064PubMed Iwamoto, I, Douchi, T, Kosha, S, Murakami, M, Fujino, T, Nagata, Y 2000Relationships between serum leptin level and regional bone mineral density, bone metabolic markers in healthy women.Acta Obstet Gynecol Scand7910601064PubMed
4.
go back to reference Pasco, JA, Henry, MJ, Kotowicz, MA, Collier, GR, Ball, MJ, Ugoni, AM, Nicholson, GC 2001Serum leptin levels are associated with bone mass in nonobese women.J Clin Endocrinol Metab8618841887PubMed Pasco, JA, Henry, MJ, Kotowicz, MA, Collier, GR, Ball, MJ, Ugoni, AM, Nicholson, GC 2001Serum leptin levels are associated with bone mass in nonobese women.J Clin Endocrinol Metab8618841887PubMed
5.
go back to reference Thomas, T, Burguera, B, Melton III, LJ, Atkinson, EJ, O’Fallon, WM, Riggs, BL, Khosla, S 2001Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women.Bone29114120PubMed Thomas, T, Burguera, B, Melton III, LJ, Atkinson, EJ, O’Fallon, WM, Riggs, BL, Khosla, S 2001Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women.Bone29114120PubMed
6.
go back to reference Thomas, T, Gori, F, Khosla, S, Jensen, MD, Burguera, B, Riggs, BL 1999Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes.Endocrinology14016301638PubMed Thomas, T, Gori, F, Khosla, S, Jensen, MD, Burguera, B, Riggs, BL 1999Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes.Endocrinology14016301638PubMed
7.
go back to reference Cooper, C, Fall, C, Egger, P, Hobbs, R, Eastell, R, Barker, D 1997Growth in infancy and bone mass in later life.Ann Rheum Dis56721 Cooper, C, Fall, C, Egger, P, Hobbs, R, Eastell, R, Barker, D 1997Growth in infancy and bone mass in later life.Ann Rheum Dis56721
8.
go back to reference Dallasso, HM, Morgan, K, Bassy, EJ, Ebrahim, SBJ, Fentem, PH, Arie, THD 1988Levels of customary physical activity among the old and very old living at home.J Epidemiol Community Health42121127PubMed Dallasso, HM, Morgan, K, Bassy, EJ, Ebrahim, SBJ, Fentem, PH, Arie, THD 1988Levels of customary physical activity among the old and very old living at home.J Epidemiol Community Health42121127PubMed
9.
go back to reference Carter, DR, Bouxsein, ML, Marcus, R 1992New approaches for interpreting projected bone densitometry data.J Bone Miner Res7137145PubMed Carter, DR, Bouxsein, ML, Marcus, R 1992New approaches for interpreting projected bone densitometry data.J Bone Miner Res7137145PubMed
10.
go back to reference Kellgren, JHLawrence, JS eds. 1963Epidemiology of chronic rheumatism: Atlas of standard radiographs.BlackwellOxford Kellgren, JHLawrence, JS eds. 1963Epidemiology of chronic rheumatism: Atlas of standard radiographs.BlackwellOxford
11.
go back to reference Thomas, M, Goddard, E, Hickman, M, Hunter, P 1992General Household Survey.OPCS Social Survey DivisionHMSQ, London Thomas, M, Goddard, E, Hickman, M, Hunter, P 1992General Household Survey.OPCS Social Survey DivisionHMSQ, London
12.
go back to reference Dennison, E, Eastell, R, Fall, CHD, Kellingray, S, Wood, PJ, Cooper, C 1999Determinants of bone loss in elderly men and women: a prospective population-based study.Osteoporosis Int10384391CrossRef Dennison, E, Eastell, R, Fall, CHD, Kellingray, S, Wood, PJ, Cooper, C 1999Determinants of bone loss in elderly men and women: a prospective population-based study.Osteoporosis Int10384391CrossRef
13.
go back to reference Jenkins, AB, Markovic, TP, Fleury, A, Campbell, LV 1997Carbohydrate intake and short-term regulation of leptin in humans.Diabetologia40348351 Jenkins, AB, Markovic, TP, Fleury, A, Campbell, LV 1997Carbohydrate intake and short-term regulation of leptin in humans.Diabetologia40348351
14.
go back to reference Ducy, P, Amling, M, Takeda, S, Priemel, M, Schilling, AF, Beil, FT, Shen, JH, Vinson, C, Rueger, JM, Karsenty, G 2000Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.Cell100197200PubMed Ducy, P, Amling, M, Takeda, S, Priemel, M, Schilling, AF, Beil, FT, Shen, JH, Vinson, C, Rueger, JM, Karsenty, G 2000Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.Cell100197200PubMed
15.
go back to reference Farooqi, IS, Jebb, SA, Langmack, G, Lawrence, E, Cheetham, CH, Prentice, AM, Hughes, IA, McCamish, MA, O’Rahilly, S 1999Brief report: effects of recombinant leptin therapy in a child with congenital leptin deficiency.N Engl J Med341879884CrossRefPubMed Farooqi, IS, Jebb, SA, Langmack, G, Lawrence, E, Cheetham, CH, Prentice, AM, Hughes, IA, McCamish, MA, O’Rahilly, S 1999Brief report: effects of recombinant leptin therapy in a child with congenital leptin deficiency.N Engl J Med341879884CrossRefPubMed
16.
go back to reference Thomas, T, Burguera, B 2002Is leptin the link between fat and bone mass?J Bone Miner Res1715631569 Thomas, T, Burguera, B 2002Is leptin the link between fat and bone mass?J Bone Miner Res1715631569
17.
go back to reference Burguera, B, Hofbauer, LC, Thomas, T, Gori, F, Evans, GL, Khosla, S, Riggs, BL, Turner, RT 2001Leptin reduces ovariectomy-induced bone loss in rats.Endocrinology14235463553PubMed Burguera, B, Hofbauer, LC, Thomas, T, Gori, F, Evans, GL, Khosla, S, Riggs, BL, Turner, RT 2001Leptin reduces ovariectomy-induced bone loss in rats.Endocrinology14235463553PubMed
18.
go back to reference Bassilana, F, Susa, M, Keller, HJ, Halleux, C 2000Human mesenchymal stem cells undergo osteogenic differentiation express leptin and functional leptin receptor .J Bone Miner Res15S378 Bassilana, F, Susa, M, Keller, HJ, Halleux, C 2000Human mesenchymal stem cells undergo osteogenic differentiation express leptin and functional leptin receptor .J Bone Miner Res15S378
19.
go back to reference Steppan, CM, Crawford, DT, Chidsey–Frink, KL, Ke, H, Swick, AG 2000Leptin is a potent stimulator of bone growth in ob/ob mice.Regul Pep927378CrossRef Steppan, CM, Crawford, DT, Chidsey–Frink, KL, Ke, H, Swick, AG 2000Leptin is a potent stimulator of bone growth in ob/ob mice.Regul Pep927378CrossRef
20.
go back to reference Reseland, JE, Syversen, U, Bakke, I, Quigstad, G, Eide, LG, Hjertner, O, Gordeladzej, O, Drevon, CA 2001Leptin is expressed in and secreted from primary cultures of human osteoblast and promotes bone mineralisation.J Bone Miner Res1614261433 Reseland, JE, Syversen, U, Bakke, I, Quigstad, G, Eide, LG, Hjertner, O, Gordeladzej, O, Drevon, CA 2001Leptin is expressed in and secreted from primary cultures of human osteoblast and promotes bone mineralisation.J Bone Miner Res1614261433
21.
go back to reference Yamauchi, M, Sugimoto, T, Yamaguchi, T, Nakaoka, D, Kanzawa, M, Yano, S, Ozuru, R, Sugishita, T, Chihara, K 2001Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women.Clin Endocrinol55341347CrossRef Yamauchi, M, Sugimoto, T, Yamaguchi, T, Nakaoka, D, Kanzawa, M, Yano, S, Ozuru, R, Sugishita, T, Chihara, K 2001Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women.Clin Endocrinol55341347CrossRef
22.
go back to reference Kennedy, A, Gettys, TW, Watson, P, Wallace, P, Ganaway, E, Pan, Q, Garvey, WT 1997The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure.J Clin Endocrinol Metab8212931300PubMed Kennedy, A, Gettys, TW, Watson, P, Wallace, P, Ganaway, E, Pan, Q, Garvey, WT 1997The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure.J Clin Endocrinol Metab8212931300PubMed
23.
go back to reference Sato, M, Takeda, N, Sarui, H, Takami, K, Hayashi, M, Sasaki, A, Kawachi, S, Yoshino, K, Yasuda, K 2001Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men.J Clin Endocrinol Metab8652735276PubMed Sato, M, Takeda, N, Sarui, H, Takami, K, Hayashi, M, Sasaki, A, Kawachi, S, Yoshino, K, Yasuda, K 2001Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men.J Clin Endocrinol Metab8652735276PubMed
24.
go back to reference Blain, H, Vuillemin, A, Guillemin, F, Durant, R, Hanesse, B, de Talance, N, Doucet, B, Jeandel, C 2002Serum leptin level is a predictor of bone mineral density in postmenopausal women.J Clin Endocrinol Metab8710301035PubMed Blain, H, Vuillemin, A, Guillemin, F, Durant, R, Hanesse, B, de Talance, N, Doucet, B, Jeandel, C 2002Serum leptin level is a predictor of bone mineral density in postmenopausal women.J Clin Endocrinol Metab8710301035PubMed
25.
go back to reference Ruhl, CE, Everhart, JE 2002Relationship of serum leptin concentration with bone mineral density in the United States population.J Bone Mines Res1718961903 Ruhl, CE, Everhart, JE 2002Relationship of serum leptin concentration with bone mineral density in the United States population.J Bone Mines Res1718961903
Metadata
Title
Plasma Leptin Concentration and Change in Bone Density Among Elderly Men and Women: The Hertfordshire Cohort Study
Authors
E. M. Dennison
H. E. Syddall
C. H. Fall
M. K. Javaid
N. K. Arden
D. I. W. Phillips
C. Cooper
Publication date
01-05-2004
Publisher
Springer-Verlag
Published in
Calcified Tissue International / Issue 5/2004
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-002-0017-x

Other articles of this Issue 5/2004

Calcified Tissue International 5/2004 Go to the issue

OriginalPaper

Announcements

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.